Mr. Xie Zhiyong (谢志永), an executive Director and the Chief Executive Officer of our Company. He is primarily responsible for the overall management of our Group.
Mr. Xie had over 22 years of experience in the neuro-intervention industry. Prior to joining our Group, from January 1999 to March 2012, Mr. Xie successively served as a R&D engineer, a manager of the stent R&D department and a R&D director at Shanghai MicroPort Medical, where he was primarily responsible for R&D of coronary stents, peripheral vascular products and neuro-interventional products including leading the R&D work for APOLLO. Mr. Xie was awarded the Second Prize for National Science and Technology Award (国家科学技术进步奖二等奖) by the State Council in February 2007 and December 2014, the First Prize for the Science and Technology Award of Shanghai (上海市科学技术奖一等奖) by the Shanghai Municipal Government in November 2009 and the Second Prize for the Science and Technology Award of Shanghai Pudong New Area (上海市浦东新区科技进步奖二等奖) by the People’s Government of Shanghai Pudong New Area in January 2017. He was also recognized as a Leading Talent of Shanghai (上海市领军人才) by the Organization Department of CPC Shanghai Committee (中共上海市委组织部) and Shanghai Municipal Human Resources and Social Security Bureau (上海市人力资源和社会保障局) in February 2020 and a Senior Engineer (正高级工程師) by the Shanghai Municipal Human Resources and Social Security Bureau (上海市人力资源和社会保障局) in December 2020.
Mr. Xie graduated from Shanghai Jiao Tong University (上海交通大学) in the PRC with a major in communications engineering in July 2004 and obtained his master’s degree in project management from Zhejiang University (浙江大学) in the PRC in June 2011.